Blog: Product Liability
- June 2026 Roundup Settlement Update: King v. Monsanto Raises Serious Questions
Jun 17, 2026
The proposed King v. Monsanto Roundup class settlement has drawn intense scrutiny, and for good reason. The headline number is enormous: up to $7.25 billion to resolve current and future claims involving alleged Roundup exposure and non-Hodgkin lymphoma. But the process behind the deal has raised serious concerns. The class action was filed in the Circuit Court of the City of St. Louis on February 17, 2026, and the settlement agreement was dated and filed...Read More - June 2026 Roundup Supreme Court Update: Durnell Case Puts Monsanto’s FIFRA Preemption Defense Before the Court
Jun 4, 2026
The U.S. Supreme Court is reviewing Monsanto Company v. Durnell, a Roundup failure-to-warn case arising from a Missouri plaintiff’s verdict. A jury found for John Durnell on his strict liability failure-to-warn claim and awarded $1.25 million in compensatory damages. The Missouri Court of Appeals affirmed the judgment, and the Missouri Supreme Court declined further review before Monsanto sought review in the U.S. Supreme Court. The issue before the Court is whether the Federal Insecticide, Fungicide,...Read More - May 2026: The Roundup Litigation to Date
May 28, 2026
Roundup litigation remains one of the country’s most closely watched product liability battles. Plaintiffs contend that repeated exposure to glyphosate-based Roundup can cause or contribute to non-Hodgkin’s lymphoma, especially after years of use at home, at work, or in agricultural, landscaping, and groundskeeping settings. The cases involve dermal exposure while spraying, mixing, applying, or cleaning up the product. Plaintiffs have pointed to genotoxicity and oxidative stress as mechanisms of action relevant to carcinogenesis, and they...Read More - When Everyday Tech Becomes a Hazard: The Intersection of Consumer Electronics and Medical Devices
Jan 15, 2026
Most of us carry a small electronic device in our pockets and on our wrists at all times. Smartphones, wireless earbuds, and fitness trackers are inseparable from modern life. At the same time, millions of Americans rely on life-sustaining medical devices like pacemakers, implantable cardioverter defibrillators (ICDs), and insulin pumps. These two worlds do not always coexist safely. The FDA and peer-reviewed medical literature have described circumstances where magnets and other electromagnetic sources in consumer...Read More - Senate Introduces "Toxic Cabin Air" Bill
Mar 30, 2022
In mid-April, Boeing will face the first ever jury trial involving claims that it defectively designed its older aircraft in ways that failed to protect pilots, crew, and passengers from the risk of "toxic cabin air" events. Now, just weeks before the start of that trial, Senators Diane Feinstein (D-Calif.), Richard Blumenthal (D-Conn.), and John Garamendi (D-Calif.) have introduced a bipartisan-sponsored bill in the Senate, entitled Cabin Air Safety Act of 2022." In a press...Read More - Boeing Trial Set for April 2022
Feb 18, 2022
The nation's first jury trial in a toxic cabin air injury case, Weiland v. Boeing, will take place in Chicago in April 2022. The case involves the tragic death of an American Airlines pilot, Captain Ronald Weiland, whose family is suing Boeing over his exposure to toxic fumes on a Boeing 767 aircraft in 2016. Captain Weiland's family contends that his exposure to the toxic air triggered his development of ALS (amyotrophic lateral sclerosis), which...Read More - Philadelphia Mass Tort Program: In re Risperdal
Feb 9, 2022
The Philadelphia Court of Common Pleas has announced the appointment of attorney T. Matthew "Matt" Leckman as plaintiffs' liaison counsel, along with Rosemary Pinto, Esq. (Feldman & Pinto) for the Philadelphia mass tort program In re Risperdal. Through the joint venture Littlepage Booth Leckman (LBL), Matt Leckman and his partners Zoe Littlepage and Rainey Booth represent young men who took Risperdal and developed gynecomastia (male breast growth) as a result. A number of Risperdal cases...Read More - Philips Respironics CPAP and BiPAP Recall
Aug 16, 2021
Philips Respironics has issued a voluntary recall of various ventilation and sleep apnea machines due to the health and safety risks posed by the design of the machines. Specifically, Philips acknowledges that the polyester-based polyurethane (PE-PUR) sound abatement foam lining the inside of the airway systems in these devices can degrade into particles that are inhaled by the patient and can off-gas toxic chemicals. The recall covers a variety of both CPAP (continuous positive airway...Read More - Peloton Recall Announced
May 5, 2021
Just this morning, the United States Consumer Product Safety Commission and Peloton announced two voluntary recalls of Peloton's Tread and Tread+. One death and over 70 safety incidents have been reported. Consumers are being directed to stop using these products immediately and to contact the company for a return, full refund, or other appropriate remedy, depending on the model. If you or a loved one has experienced a serious injury as a result of a...Read More - Hawaii Judge Orders Makers of Plavix to Pay $834 Million
Feb 26, 2021
In 2014, the Attorney General of Hawaii brought suit against Bristol-Myers Squibb Co and Sanofi SA for violating consumer protection laws by marketing Plavix without disclosing that the drug could have limited or no effect for non-white patients. Last week, after a four week long bench trial held over Zoom, Judge Ochiai ordered the joint drug manufacturers to pay a total of $834 Million to the state of Hawaii. The court found that between December...Read More